Matthew M. Walsh - Chief Financial Officer at Organon & Co.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
OGN on NYSE
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Matthew M. Walsh since 7/6/2023

Holdings reported by Matthew M. Walsh for Organon & Co.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 88,326 $1.73 M $19.61 May 4, 2024 Direct
Restricted Stock Units 0 $0 $19.61 May 4, 2024 Direct Common Stock
Stock Option (right to buy) 185,185 Mar 29, 2024 Direct Common Stock

Transactions reported by Matthew M. Walsh for Organon & Co.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership